Necessary Ventures | Activity

Essay

Neil Devani published a detailed essay on the commodities investment thesis at Necessary Ventures, covering cost leadership, parameterization, and portfolio examples including Magrathea, Rubi, Circularity Fuels, Nevoya, and Terra Energy.

Necessary Ventures

Necessary VenturesNecessary Ventures

necessary.vcAUG 19, 2026

AUG 19, 2026

Essay

Published a Necessary Nuggets essay covering Q1 pre-seed funding patterns and climate/energy startup activity.

The mission to reduce emissions is back on.

Necessary Ventures

necessary.vcJUN 4, 2026

JUN 4, 2026

Essay

Published a Necessary Nuggets essay on AI automation limits, seed market dynamics, and climate-tech commercialization.

Is automation overr-AI-ted?

Necessary Ventures

necessary.vcMAY 2, 2026

MAY 2, 2026

Essay

Published essay on SPACs' return as alternative path to public markets for deep-tech companies.

Getting SPAC to Deep Tech Public Markets

Necessary Ventures

necessary.vcMAR 26, 2026

MAR 26, 2026

Investment

Participated in Arc's $50M Series C for electric commercial and defense vessel powertrains.

Arc

Arc Necessary Ventures

arcboats.comMAR 19, 2026 necessary.vc

MAR 19, 2026

Investment

Participated in Nitra's financing, including a $50M Series B for its AI-native healthcare practice operating platform.

Nitra

Nitra Necessary Ventures

prnewswire.comMAR 10, 2026

MAR 10, 2026

Investment

Participated in Arc's $50M Series C round led by Eclipse for electric propulsion systems.

Arc

Arc Necessary Ventures

necessary.vcMAR 2026

MAR 2026

Essay

Published essay examining how AI research has shifted from academia to industry.

Academia is too slow for AI

Necessary Ventures

necessary.vcFEB 19, 2026

FEB 19, 2026

Essay

Published essay on venture capital market recovery and renewed momentum.

Venture is in its comeback era

Necessary Ventures

necessary.vcJAN 8, 2026

JAN 8, 2026

Essay

Published essay on meaningful paradigm shifts in AI rather than single breakthrough.

AI Took Small Steps in 2025. That's the Point.

Necessary Ventures

necessary.vcJAN 2, 2026

JAN 2, 2026

Exit

Portfolio company Recursion completed IPO in June 2025.

Recursion

Recursion Necessary Ventures

necessary.vcJUN 2025

JUN 2025

Exit

Portfolio company Omada Health completed IPO in May 2025.

Omada Health

Omada Health Necessary Ventures

necessary.vcMAY 2025

MAY 2025

Essay

Necessary Ventures published a detailed biotech investment thesis covering platform biotech companies combining computational power with scalable wet-lab systems, AI/ML for protein discovery, and areas of interest like predictive toxicity modeling and GPCR discovery.

Necessary Ventures

Necessary VenturesNecessary Ventures

necessary.vcAPR 25, 2025

APR 25, 2025

Necessary Ventures Activity

Neil Devani published a detailed essay on the commodities investment thesis at Necessary Ventures, covering cost leadership, parameterization, and portfolio examples including Magrathea, Rubi, Circularity Fuels, Nevoya, and Terra Energy.

Necessary Ventures participated in Kanurra's Seed round in July 2026. Kanurra is a business/productivity software company.

Published a Necessary Nuggets essay covering Q1 pre-seed funding patterns and climate/energy startup activity.

Published a Necessary Nuggets essay on AI automation limits, seed market dynamics, and climate-tech commercialization.

Published essay on SPACs' return as alternative path to public markets for deep-tech companies.

Participated in Arc's $50M Series C for electric commercial and defense vessel powertrains.

Participated in Nitra's financing, including a $50M Series B for its AI-native healthcare practice operating platform.

Participated in Arc's $50M Series C round led by Eclipse for electric propulsion systems.

Published essay examining how AI research has shifted from academia to industry.

Published essay on venture capital market recovery and renewed momentum.

Published essay on meaningful paradigm shifts in AI rather than single breakthrough.

Portfolio company Recursion completed IPO in June 2025.

Portfolio company Omada Health completed IPO in May 2025.

Necessary Ventures published a detailed biotech investment thesis covering platform biotech companies combining computational power with scalable wet-lab systems, AI/ML for protein discovery, and areas of interest like predictive toxicity modeling and GPCR discovery.